Home › Spinal Muscular Atrophy › Texas › Dallas
Spinal Muscular Atrophy clinical trials in Dallas, TX
3 studies for Spinal Muscular Atrophy are looking for participants at sites in and around Dallas (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study Evaluating the Effectiveness and Safety of Risdiplam Administered as an Early Intervention in Pediatric Participants With Spinal Muscular Atrophy After Gene Therapy
RecruitingPhase 4
- The University of Texas Southwestern Medical Center at Dallas, Dallas
A Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular Atrophy
RecruitingPhase 2
- University of Texas Southwestern Medical Center, Dallas
A Study Evaluating the Effectiveness and Safety of Risdiplam Administered in Pediatric Patients With Spinal Muscular Atrophy Who Experienced a Plateau or Decline in Function After Gene Therapy
RecruitingPhase 4
- University of Texas Southwestern Medical Center, Dallas
About Spinal Muscular Atrophy
Spinal muscular atrophy (SMA) attacks nerve cells in the spinal cord, weakening voluntary muscles. Read about the genetics, types, and what may help.
More about Spinal Muscular Atrophy on MedlinePlus
Spinal Muscular Atrophy trials in other cities
- New York City, NY9 studies
- Mountain View, CA9 studies
- Philadelphia, PA7 studies
- Chicago, IL6 studies
- Norfolk, VA6 studies
- Grand Rapids, MI6 studies
- Boston, MA5 studies
- Houston, TX5 studies
- Little Rock, AR4 studies
- Lewisville, TX4 studies
- Aurora, CO4 studies
- Phoenix, AZ4 studies
Other studies in Dallas
- Breast Cancer55 studies
- Non-Small Cell Lung Cancer52 studies
- Metastatic Cancer42 studies
- Heart Failure42 studies
- Cancer (all types)37 studies
- Prostate Cancer36 studies
- Colorectal Cancer33 studies
- Obesity30 studies
- Ovarian Cancer28 studies
- Bladder Cancer27 studies
- Lung Cancer27 studies
- Endometrial Cancer24 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.